FHI 360 will be participating in the International AIDS Society Conference on HIV Science. IAS 2017 is a crucial point when the scientific advances within the HIV response are center stage. The focus at IAS 2017 will be on new insights that will enable programs to efficiently implement prevention, treatment, care and support services with impact on epidemic control at the forefront.

FHI 360 congratulates its partner, Shanghai Dahua Pharmaceutical Co., Ltd. (Dahua), on achieving prequalification from the World Health Organization (WHO) of its two-rod contraceptive implant, Levoplant, which is also referred to as Sino-implant (II). By attaining WHO prequalification, Levoplant/Sino-implant (II) is now recognized as meeting international quality standards.

With the passing of Dr. Babatunde Osotimehin, Executive Director of UNFPA, the global health community has lost a true champion for women’s rights and reproductive health.